Sanofi’s new insulin and GLP-1 combination Suliqua has received marketing approval from the European Commission. The once-daily treatment combines Lantus (insulin glargine) and with Lyxumia ...
Researchers are evaluating a structured lifestyle programme for women with type 2 diabetes. A research team King’s College London’s Florence Nightingale Faculty of Nursing and Midwifery are now ...
A campaign to raise awareness of a national drive to prevent type 2 diabetes is taking place in the East Midlands. Diabetes Prevention Week – which takes place across the region between Monday, ...
The long-term impact of an intensive lifestyle intervention on cardiovascular risk factors in people with type 2 diabetes has been proven in real-world clinical practice. Results from a follow-up ...
Liraglutide 1.2 mg has proved “cost-effective” compared to alternative daily administered GLP-1 receptor agonists for the treatment of type 2 diabetes in the UK, a study has ...
The rate of type 2 diabetes in middle-aged people has more than doubled in 20 years, Public Health England has today revealed. A total of 2.8 per cent of men in England were diagnosed with ...
Campaigners say moves to bring in a central tax on sugary drinks will “help protect our children’s future health”. The results of a Government consultation on introducing in the levy from April ...
Football is being used as a vehicle to promote the benefits of healthy eating and exercise as part of a drive to help prevent Type 2 diabetes across Hampshire. Aldershot Town FC has strengthened ...
The future of the NHS is at risk because the cost of treating diabetes could hit £17 billion by 2035, health experts have warned. According to Public Health England there are currently 4.5 ...
Certain genetic variants related to reduced low-density lipoprotein cholesterol may raise the risk of type 2 diabetes, according to a new study. More than half a million people were meta-analysed ...